PTEN loss of function occurs in a wide spectrum of human cancers through various genetic alterations including point mutations (missense and nonsense mutations), large chromosomal deletions (homozygous/heterozygous deletion, frameshift, inframe deletion, and truncation), and epigenetic mechanisms as hypermethylation of the PTEN promoter region. Here, PTEN is linked to cancer.